| Synonyms: | |
| Status: | Approved (2020) |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| ATC: | L04AA47 |
| UNII: | 74T7185BMM |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| BINDING AGENT | B-lymphocyte antigen CD19 binding agent | PubMed |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Neuromyelitis Optica | 4 | D009471 | ClinicalTrials |
| Immunoglobulin G4-Related Disease | 3 | D000077733 | ClinicalTrials |
| Myasthenia Gravis | 3 | D009157 | ClinicalTrials |
| Encephalitis, Japanese | 2 | D004672 | ClinicalTrials |
| Multiple Myeloma | 2 | D009101 | ClinicalTrials |
| Lymphoma, Large B-Cell, Diffuse | 2 | D016403 | ClinicalTrials |
| Leukemia, Lymphocytic, Chronic, B-Cell | 2 | D015451 | ClinicalTrials |
| Multiple Sclerosis | 1 | D009103 | ClinicalTrials |
| Hematologic Neoplasms | 1 | D019337 | ClinicalTrials |
| Lymphoma | 1 | D008223 | ClinicalTrials |
| Scleroderma, Localized | 1 | D012594 | ClinicalTrials |
| Neoplasms | 1 | D009369 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL2109334 |
| FDA SRS | 74T7185BMM |
CONTENTS